Skip to main content
Robert S. Ohgami, MD, PhD, FCAP
Vice President, Institute for Research and Innovation in Diagnostic and Precision Medicine
Medical Director: Hematopathology
Professor, University of Utah School of Medicine
Specialties
Hematopathology
Molecular pathology
Translational research
Innovation
Education
Medical Degree—Harvard Medical School
Doctorate Degree—Harvard University
Residency—Anatomic Pathology, Stanford University
Fellowship—Hematopathology, Stanford University
Certification/Affiliations
American Board of Pathology: Anatomic Pathology and Hematology
University of Utah David Eccles School of Business: Leading with Equity, Diversity, and Inclusion
Research Interests
Translational molecular pathology
Clinical laboratory testing
Hematopathology
Applied artificial intelligence
Awards
Berard-Dorfman Founders Award, Society for Hematopathology
Faculty Scholar Mentor, Fulbright U.S. Scholar Program
Principal Investigator and Mentor, Regeneron Science Talent Search Scholar
Anatomic Pathology Junior Faculty Teaching Award, Stanford University Department of Pathology
Clinical Pathology Junior Faculty Teaching Award, Stanford University Department of Pathology
Cum Laude, Harvard Medical School
Summa Cum Laude, Princeton University
Pyka Prize for Excellence in Physics, Princeton University
Recent Publications
Alaggio R, et al. The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid neoplasms [published correction appears in Leukemia . 2023]. Leukemia . 2022;36(7):1720–48.
Guney E, et al. Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS . Blood Adv . 2023;7(13):3307–11.
Ohgami RS, et al. An analysis of the pathologic features of blastic plasmacytoid dendritic cell neoplasm based on a comprehensive literature database of cases . Arch Pathol Lab Med . 2023;147(7):837–46.
Xiao A, et al. TFG::ALK fusion in ALK positive large B-cell lymphoma: a case report and review of literature . Front Oncol . 2023;13:1174606.
Butzmann A, et al. Mutations in JAK/STAT and NOTCH1 genes are enriched in post-transplant lymphoproliferative disorders . Front Oncol. 2022;11:790481.
Güney E, et al. A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome . Blood Adv . 2022;6(10):3189–93.
Kikuchi A, et al. Pathology updates and diagnostic approaches to haemophagocytic lymphohistiocytosis .Histopathology . 2022;80(4):616–26.
Lu KL, et al. Cytomorphologic features of pediatric-type follicular lymphoma on fine needle aspiration biopsy: case series and a review of the literature. J Am Soc Cytopathol . 2022;11(5):281–94
Saglam A, et al. Indolent T-lymphoblastic proliferation: a systematic review of the literature analyzing the epidemiologic, clinical, and pathologic features of 45 cases . Int J Lab Hematol . 2022;44(4):700–11.
Singh KI, et al. Case report: Castleman disease with an associated stromal spindle cell proliferation, PDGFRB mutation and p53 Expression: clonal origins of a rare disease . Front Oncol. 2022;12:857606.
Butzmann A, et al. A review of genetic abnormalities in unicentric and multicentric Castleman disease . Biology (Basel) . 2021;10(4):251.
Chen JA, et al. Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance . Blood Adv . 2021;5(17):3492–96.
Han SY, et al. Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21) . Blood Adv . 2021;5(10):2481–89.
Kennedy VE, et al. A case of EBV-negative aggressive NK-cell leukemia: use of next-generation sequencing in demystifying a diagnostic dilemma and guiding clinical care . Clin Lymphoma Myeloma Leuk . 2021;21(7):e583–87.
Ling H, et al. Measurement of cell volume using in-line digital holography . Microscopy (Oxf). 2021;70(4):333–39.
Singh K, et al. A meta- analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity. Int J Lab Hematol . 2021;43(2):324–28.
Singh K, et al. Point mutation specific antibodies in B-cell and T-cell lymphomas and leukemias: targeting IDH2, KRAS, BRAF and other biomarkers RHOA, IRF8, MYD88, ID3, NRAS, SF3B1 and EZH2 . Diagnostics (Basel). 2021;11(4):600.
Ustun C, et al. Core-binding factor acute myeloid leukemia with inv(16): older age and high white blood cell count are risk factors for treatment failure . Int J Lab Hematol . 2021;43(1):e19–e25.
Yang F, et al. Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues . Science . 2021;372(6543):738–41.
Brar N, et al. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations . Histopathology . 2020;77(6):984–88.
Butzmann A, et al. A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis . Int J Mol Med . 2020;46(4):1466–76.
Gars E, et al. The life and death of the germinal center . Ann Diagn Pathol. 2020;44:151421.
Hoffmann JC, et al. A long-term study of persistent Sézary Syndrome: evidence for antigen shift by multiparameter flow cytometry and its significance in overall survival . Am J Dermatopathol . 2020;42(6):389–96.
Jangam D, et al. TBL1XR1Mutations in primary marginal zone lymphomas of ocular adnexa are associated with unique morphometric mhenotypes . Curr Eye Res . 2020;45(12):1583–89.
Lauw MIS, et al. Primary central nervous system lymphomas: a diagnostic overview of key histomorphologic, immunophenotypic, and genetic features . Diagnostics (Basel). 2020;10(12):1076.
Tsai AG, et al. Multiplexed single-cell morphometry for hematopathology diagnostics . Nat Med . 2020;26(3):408–17.
Wang L, et al. Hypodiploid B-lymphoblastic leukemia presenting as an isolated orbital mass prior to systemic involvement: a case report and review of the literature . Diagnostics (Basel). 2020;11(1):25.
Wen KW, et al. Complexities in the diagnosis of large B-cell lymphomas, classic Hodgkin lymphomas and overlapping peripheral T-cell lymphomas simplified: An evidence-based guide . Ann Diagn Pathol . 2020;46:151534.
Werstein B, et al. Molecular discordance between myeloid sarcomas and concurrent bone marrows occurs in actionable genes and is associated with worse overall survival . J Mol Diagn . 2020;22(3):338–45.
Yao K, et al. Artificial intelligence in pathology: a simple and practical guide . Adv Anat Pathol . 2020;27(6):385–93.
Hoffmann JC, et al. Rosai-Dorfman disease of the breast with variable IgG4+ plasma cells: A diagnostic mimicker of other malignant and reactive entities . Am J Surg Pathol . 2019;43(12):1653–60.
Kumar J, et al. Indolent in situ B-Cell neoplasms with MYC rearrangements show somatic mutations in MYC and TNFRSF14 by next- generation sequencing . Am J Surg Pathol . 2019;43(12):1720–25.
Sridhar K, et al. Molecular genetic testing methodologies in hematopoietic diseases: current and future methods . Int J Lab Hematol . 2019;41 Suppl 1:102–16.